Characteristics of subjective cognitive decline associated with amyloid positivity.

Details

Ressource 1Download: 34877782_BIB_D70F024AB648.pdf (1680.13 [Ko])
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_D70F024AB648
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Characteristics of subjective cognitive decline associated with amyloid positivity.
Journal
Alzheimer's & dementia
Author(s)
Janssen O., Jansen W.J., Vos SJB, Boada M., Parnetti L., Gabryelewicz T., Fladby T., Molinuevo J.L., Villeneuve S., Hort J., Epelbaum S., Lleó A., Engelborghs S., van der Flier W.M., Landau S., Popp J., Wallin A., Scheltens P., Rikkert M.O., Snyder P.J., Rowe C., Chételat G., Ruíz A., Marquié M., Chipi E., Wolfsgruber S., Heneka M., Boecker H., Peters O., Jarholm J., Rami L., Tort-Merino A., Binette A.P., Poirier J., Rosa-Neto P., Cerman J., Dubois B., Teichmann M., Alcolea D., Fortea J., Sánchez-Saudinós M.B., Ebenau J., Pocnet C., Eckerström M., Thompson L., Villemagne V., Buckley R., Burnham S., Delarue M., Freund-Levi Y., Wallin Å.K., Ramakers I., Tsolaki M., Soininen H., Hampel H., Spiru L., Tijms B., Ossenkoppele R., Verhey FRJ, Jessen F., Visser P.J.
Working group(s)
Alzheimer's Disease Neuroimaging Initiative, FACEHBI study group, PREVENT-AD research group
ISSN
1552-5279 (Electronic)
ISSN-L
1552-5260
Publication state
Published
Issued date
10/2022
Peer-reviewed
Oui
Volume
18
Number
10
Pages
1832-1845
Language
english
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural
Publication Status: ppublish
Abstract
The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited.
In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort, we investigated the associations of SCD-specific characteristics (informant confirmation, domain-specific complaints, concerns, feelings of worse performance) demographics, setting, apolipoprotein E gene (APOE) ε4 carriership, and neuropsychiatric symptoms with amyloid positivity.
Between cohorts, amyloid positivity in 70-year-olds varied from 10% to 76%. Only older age, clinical setting, and APOE ε4 carriership showed univariate associations with increased amyloid positivity. After adjusting for these, lower education was also associated with increased amyloid positivity. Only within a research setting, informant-confirmed complaints, memory complaints, attention/concentration complaints, and no depressive symptoms were associated with increased amyloid positivity. Feelings of worse performance were associated with less amyloid positivity at younger ages and more at older ages.
Next to age, setting, and APOE ε4 carriership, SCD-specific characteristics may facilitate the identification of amyloid-positive individuals.
Keywords
Humans, Amyloid, Amyloidogenic Proteins, Amyloidosis, Apolipoprotein E4/genetics, Biomarkers, Brain/metabolism, Cognitive Dysfunction/genetics, Cognitive Dysfunction/psychology, Positron-Emission Tomography, Alzheimer's disease, amyloid, cerebrospinal fluid, positron emission tomography, subjective cognitive decline
Pubmed
Web of science
Open Access
Yes
Create date
11/12/2021 11:56
Last modification date
25/01/2024 7:45
Usage data